-
EP3888685
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3888685
| EP3888685 - DRUG CONTAINING LIVER TARGETING SPECIFIC LIGAND AND THYROID HORMONE RECEPTOR AGONIST [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 27.06.2024 Database last updated on 19.10.2024 | |
| Former | Grant of patent is intended Status updated on 25.02.2024 | ||
| Former | Examination is in progress Status updated on 24.08.2023 | ||
| Former | Request for examination was made Status updated on 03.09.2021 | ||
| Former | The international publication has been made Status updated on 06.06.2020 | Most recent event Tooltip | 27.06.2024 | (Expected) grant | published on 31.07.2024 [2024/31] | Applicant(s) | For all designated states Kylonova (Xiamen) Biopharma Co., Ltd. CHEN, Qingyan Room 302, No. 120, Xin Yuan Rd., Haicang District Xiamen, Fujian 361022 / CN | [2024/31] |
| Former [2021/40] | For all designated states Kylonova (Xiamen) Biopharma Co., Ltd. CHEN, Qingyan Room 302, No. 120, Xin Yuan Rd., Haicang District Xiamen, Fujian 361022 / CN | Inventor(s) | 01 /
CUI, Kunyuan Room 302, No. 120, Xin Yuan Rd., Haicang District Xiamen, Fujian 361022 / CN | [2021/40] | Representative(s) | Cabinet Chaillot 16/20, avenue de l'Agent Sarre B.P. 74 92703 Colombes Cedex / FR | [2024/31] |
| Former [2021/40] | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE | Application number, filing date | 19889346.3 | 02.12.2019 | [2021/40] | WO2019CN122318 | Priority number, date | CN201811452803 | 30.11.2018 Original published format: CN201811452803 | [2021/40] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020108657 | Date: | 04.06.2020 | Language: | ZH | [2020/23] | Type: | A1 Application with search report | No.: | EP3888685 | Date: | 06.10.2021 | Language: | EN | [2021/40] | Type: | B1 Patent specification | No.: | EP3888685 | Date: | 31.07.2024 | Language: | EN | [2024/31] | Search report(s) | International search report - published on: | CN | 04.06.2020 | (Supplementary) European search report - dispatched on: | EP | 07.10.2022 | Classification | IPC: | A61K47/54, A61K47/56, C07H15/04, A61K31/198, A61K47/61, A61P1/16 | [2022/45] | CPC: |
A61K47/549 (EP,CN,KR,US);
A61K47/61 (CN,KR);
A61K31/198 (EP,CN,KR,US);
A61K31/325 (KR);
A61K31/404 (KR);
A61K31/44 (CN);
A61K47/54 (US);
A61K47/545 (US);
A61K47/548 (US);
A61K47/56 (EP);
A61P1/16 (EP,CN,KR,US);
C07H15/04 (EP);
Y02P20/55 (EP)
(-)
|
| Former IPC [2021/40] | A61K47/54, A61K47/61, A61P1/16 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/40] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ARZNEIMITTEL MIT AUF DIE LEBER ABZIELENDEN SPEZIFISCHEN LIGANDEN UND SCHILDDRÜSENHORMONREZEPTORAGONISTEN | [2021/40] | English: | DRUG CONTAINING LIVER TARGETING SPECIFIC LIGAND AND THYROID HORMONE RECEPTOR AGONIST | [2021/40] | French: | MÉDICAMENT CONTENANT UN LIGAND SPÉCIFIQUE CIBLANT LE FOIE ET UN AGONISTE DU RÉCEPTEUR DES HORMONES THYROÏDIENNES | [2021/40] | Entry into regional phase | 29.06.2021 | Translation filed | 29.06.2021 | National basic fee paid | 29.06.2021 | Search fee paid | 29.06.2021 | Designation fee(s) paid | 29.06.2021 | Examination fee paid | Examination procedure | 29.06.2021 | Examination requested [2021/40] | 02.11.2022 | Amendment by applicant (claims and/or description) | 23.08.2023 | Despatch of a communication from the examining division (Time limit: M04) | 21.11.2023 | Reply to a communication from the examining division | 26.02.2024 | Communication of intention to grant the patent | 07.06.2024 | Receipt of the translation of the claim(s) | 24.06.2024 | Fee for grant paid | 24.06.2024 | Fee for publishing/printing paid | Fees paid | Renewal fee | 05.10.2021 | Renewal fee patent year 03 | 23.12.2022 | Renewal fee patent year 04 | 24.11.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]EP0087564 (MILES LAB [US]); | [XI]CN107929273 (CUI KUNYUAN); |